Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $366.51 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $122.89 | 1 | $0 (2022) |
| Validus Pharmaceuticals LLC | $108.11 | 1 | $0 (2021) |
| AbbVie Inc. | $58.54 | 2 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $32.19 | 2 | $0 (2021) |
| Alkermes, Inc. | $31.18 | 1 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $13.60 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $154.07 | 2 | AstraZeneca Pharmaceuticals LP ($122.89) |
| 2021 | $212.44 | 6 | Validus Pharmaceuticals LLC ($108.11) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/29/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $122.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/13/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: CNS | ||||||
| 12/03/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: PSYCHIATRY | ||||||
| 06/17/2021 | Validus Pharmaceuticals LLC | Equetro (Drug) | Food and Beverage | Cash or cash equivalent | $108.11 | General |
| Category: CNS | ||||||
| 06/10/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: CNS | ||||||
| 01/08/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 56 | 164 | $39,109 | $7,578 |
| 2022 | 2 | 58 | 150 | $40,595 | $8,104 |
| 2021 | 1 | 37 | 115 | $24,294 | $7,060 |
| 2020 | 4 | 159 | 265 | $52,447 | $12,091 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 33 | 97 | $19,009 | $5,285 | 27.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 23 | 67 | $20,100 | $2,294 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 31 | 83 | $16,117 | $4,521 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 33 | $14,278 | $2,263 | 15.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 14 | 34 | $10,200 | $1,319 | 12.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 37 | 115 | $24,294 | $7,060 | 29.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 97 | 180 | $37,837 | $8,235 | 21.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 24 | 39 | $8,160 | $2,055 | 25.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 13 | 13 | $3,900 | $1,234 | 31.6% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 12 | 15 | $2,100 | $452.59 | 21.6% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 13 | 18 | $450.00 | $113.54 | 25.2% |
About Brennon Giles, NURSE PRACTIONER
Brennon Giles, NURSE PRACTIONER is a Psychiatric/Mental Health healthcare provider based in Wheelersburg, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2010. The National Provider Identifier (NPI) number assigned to this provider is 1194034553.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brennon Giles, NURSE PRACTIONER has received a total of $366.51 in payments from pharmaceutical and medical device companies, with $154.07 received in 2022. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($366.51).
As a Medicare-enrolled provider, Giles has provided services to 310 Medicare beneficiaries, totaling 694 services with total Medicare billing of $34,833. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health
- Location Wheelersburg, OH
- Active Since 10/04/2010
- Last Updated 08/02/2024
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1194034553
Products in Payments
- LOKELMA (Drug) $122.89
- Equetro (Drug) $108.11
- VRAYLAR (Drug) $58.54
- LATUDA (Drug) $32.19
- LYBALVI (Drug) $31.18
- REXULTI (Drug) $13.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.